SEC Info - Metlife Inc. - ‘8-K’ for 6/21/22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM i 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): i June 21, 2022

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

i Delaware

(State or Other Jurisdiction of Incorporation)


i 1-15787		i 13-4075851
(Commission File Number)		(IRS Employer Identification No.)


i 200 Park Avenue, i New York, i NY		i 10166-0188
(Address of Principal Executive Offices)		(Zip Code)

i (212) i 578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, par value $0.01	i MET	i New York Stock Exchange
i Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01	i MET PRA	i New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E	i MET PRE	i New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F	i MET PRF	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07

Submission of Matters to a Vote of Security Holders.

At MetLife, Inc.’s (the “Company’s”) annual meeting of common shareholders on June 21, 2022, the shareholders:

•

elected thirteen Directors, each for a term expiring at the Company’s 2023 annual meeting of shareholders;

•

ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2022; and

•

approved, on an advisory basis, the compensation paid to the Company’s Named Executive Officers as disclosed in the Company’s 2022 Proxy Statement.

Election of Directors:


Nominee Name	Votes For		Votes Against		Abstained		Broker Non-Votes
Cheryl W. Grisé		644,528,111		33,895,977		489,156		50,678,824
Carlos M. Gutierrez		671,202,706		7,247,734		462,804		50,678,824
Carla A. Harris		665,300,495		13,155,422		457,327		50,678,824
Gerald L. Hassell		675,636,175		2,791,448		485,621		50,678,824
David L. Herzog		665,385,845		13,052,671		474,728		50,678,824
R. Glenn Hubbard, Ph.D.		658,157,472		20,236,148		519,624		50,678,824
Edward J. Kelly, III		674,263,125		4,179,292		470,827		50,678,824
William E. Kennard		677,205,110		1,218,207		489,927		50,678,824
Michel A. Khalaf		677,001,172		1,453,057		459,015		50,678,824
Catherine R. Kinney		659,511,797		18,913,884		487,563		50,678,824
Diana L. McKenzie		675,949,548		2,512,738		450,958		50,678,824
Denise M. Morrison		668,857,352		9,600,144		455,748		50,678,824
Mark A. Weinberger		667,136,542		11,308,847		467,855		50,678,824


	Votes For		Votes Against		Abstained		Broker Non-Votes
Ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2022		692,195,933		36,924,292		471,843		0
Advisory vote to approve the compensation paid to the Company’s Named Executive Officers		646,681,597		31,245,998		985,649		50,678,824

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


METLIFE, INC.

By:		/s/ *Timothy J. Ring*
Name:		Timothy J. Ring
Title:		Vice President and Secretary

Date: June 24, 2022

This ‘8-K’ Filing	Date	Other Filings

Filed on:	6/24/22
For Period end:	6/21/22	4, DEF 14A
		List all Filings

Metlife Inc. – ‘8-K’ for 6/21/22

On: Friday, 6/24/22, at 4:34pm ET · For: 6/21/22 · Accession #: 1193125-22-181566 · File #: 1-15787

Previous ‘8-K’: ‘8-K/A’ on 6/16/22 for 4/4/22 · Next: ‘8-K’ on 7/11/22 for 7/7/22 · Latest: ‘8-K’ on / for 5/1/24 · 9 References:

Current Report — Form 8-K

Filing Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

9 Subsequent Filings that Reference this Filing